NDC 61703-305-38
Cytarabine 20 mg/mL
CYTARABINE · INJECTION, SOLUTION
Cytarabine is a chemotherapy medication given as an injection into the fluid surrounding the spinal cord to treat certain types of cancer, particularly leukemias and lymphomas that affect the central nervous system. This drug works by interfering with cancer cell growth and is typically used as part of a comprehensive cancer treatment plan.
Key Facts
- Brand Name
- Cytarabine
- Generic Name
- CYTARABINE
- NDC Code (Package)
61703-305-38- NDC Code (Product)
61703-305- Manufacturer
- Hospira, Inc.
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA071868
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 06/04/1990
Recall History
No Recall HistoryView Full Drug Page
Cytarabine — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.